Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Authors not listed
Center for Eye Research Australia · 2017
Abstract
Clinical trial investigating the role of hyperspectral imaging in the management of patients undergoing standard clinical treatment for naive neovascular choroidal membranes in age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2017). Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging. <em>Center for Eye Research Australia</em>. https://clinicaltrials.gov/study/NCT03105609
Vancouver
Anonymous. Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging. Center for Eye Research Australia. 2017.
BibTeX
@misc{anon2017Enhanc,
title = {Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging},
author = {Anonymous},
journal = {Center for Eye Research Australia},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2017
Preprint · OA
Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration
Ophthalmology 2006
Citation only
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Jaeb Center for Health Research 2023
Open access · US-GOV
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
University of Miami 2004
Open access · US-GOV
Prospective Optical Coherence Tomography (OCT) Imaging of Patients With Neovascular Age-Related Macular Degeneration (AMD) Treated With Intra-Ocular Lucentis™ (Ranibizumab): PrONTO Study
Drugs 2008
Citation only